ポル・メド・テック
Kawasaki, JP · 2 known investors
PorMedTec develops transplantable organs and tissues using genetically modified pigs for manufacturing and commercializing as regenerative medicine products. The company targets patients and healthcare systems facing severe organ shortages by providing alternatives to dialysis and other symptom-based treatments.
BiotechHealthtechMedical Devices
Founders & leadership
HN
Hiroshi NagashimaFounder, CEO and Chief Scientist
GM
Genjiro MiwaFounder, President and CEO
Investors · 2
Frequently asked questions
- What does ポル・メド・テック do?
- PorMedTec develops transplantable organs and tissues using genetically modified pigs for manufacturing and commercializing as regenerative medicine products. The company targets patients and healthcare systems facing severe organ shortages by providing alternatives to dialysis and other symptom-based treatments.
- Who founded ポル・メド・テック?
- ポル・メド・テック was founded by Hiroshi Nagashima, Genjiro Miwa.
- Who are ポル・メド・テック's investors?
- ポル・メド・テック's investors include Eight Roads Ventures, Global Brain.
- Where is ポル・メド・テック headquartered?
- ポル・メド・テック is headquartered in Kawasaki, JP.